NovaBridge Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	-	-	-	0.63	-1.55	13.86
Revenue Growth	-	-	-	-	-	-94.14%
Cost of Revenue	-	-	-	-	-	7.31
Gross Profit	-	-	-	0.63	-1.55	6.55
Selling, General & Admin	49.47	31.36	29.66	28.16	28.98	141.67
Research & Development	73.16	62.91	21.77	21.45	22.55	190.94
Operating Expenses	122.63	94.27	51.43	49.61	51.53	332.6
Operating Income	-122.63	-94.27	-51.43	-48.98	-53.08	-326.06
Interest & Investment Income	6.29	7.61	7.49	9.29	4.95	3.36
Earnings From Equity Investments	-	-	-1.04	-11.4	-64.71	-57.91
Currency Exchange Gain (Loss)	0.16	-0	-5.57	-8.04	-33.75	3.99
Other Non Operating Income (Expenses)	0.06	0.07	14.49	-0.05	5.48	4.32
EBT Excluding Unusual Items	-116.13	-86.59	-36.06	-59.18	-141.1	-372.3
Impairment of Goodwill	-	-	-	-23.04	-	-
Gain (Loss) on Sale of Investments	-1.42	-1.75	-	-	-	4.78
Asset Writedown	-	-	-1.25	-	-	-
Other Unusual Items	-	-	-12.39	-	-	-
Pretax Income	-117.55	-88.34	-49.7	-82.22	-141.1	-367.52
Income Tax Expense	-	-	-	-	0.1	-0.5
Earnings From Continuing Operations	-117.55	-88.34	-49.7	-82.22	-141.2	-367.02
Earnings From Discontinued Operations	-	-	27.47	-125.51	-229.85	-
Net Income	-117.55	-88.34	-22.23	-207.73	-371.05	-367.02
Net Income to Common	-117.55	-88.34	-22.23	-207.73	-371.05	-367.02
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	113	96	81	83	83	76
Shares Outstanding (Diluted)	113	96	81	83	83	76
Shares Change	38.28%	17.96%	-2.45%	0.86%	8.63%	11.11%
EPS (Basic)	-1.04	-0.92	-0.27	-2.50	-4.50	-4.83
EPS (Diluted)	-1.04	-0.92	-0.27	-2.50	-4.50	-4.83
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-46.67	-20.6	-106.68	-146.66	-92.32	-157.89
Free Cash Flow Per Share	-0.41	-0.21	-1.31	-1.76	-1.12	-2.08
Gross Margin	-	-	-	100.00%	-	47.25%
Operating Margin	-	-	-	-7749.37%	-	-2353.06%
Profit Margin	-	-	-	-32868.51%	-	-2648.70%
Free Cash Flow Margin	-	-	-	-23206.33%	-	-1139.46%
EBITDA	-122.53	-94.2	-51.17	-48.5	-52.87	-323.89
D&A For EBITDA	0.11	0.07	0.26	0.48	0.21	2.17
EBIT	-122.63	-94.27	-51.43	-48.98	-53.08	-326.06
Revenue as Reported	-	-	-	0.63	-1.55	13.86

SEC Filings: 10-K · 10-Q